BioSpace Article Feature: “Feeder Programs First Step in Bringing More Diversity to Pharma”

This BioSpace article, "Feeder Programs First Step in Bringing More Diversity to Pharma," highlights Roivant Sciences and Roivant Social Ventures' recently launched Diversity in Pharma Internship Program!

"Most of the treatments and cures that pharmaceutical companies focus on are for illnesses that affect white men, rather than women or people of color, said Lindsay Androski, CFA, President and CEO of Roivant Social Ventures and an independent director at Eloxx Pharmaceuticals.

“I do not believe this is because of malice but because people have a human tendency to want to make a difference in areas that have impacted them or their loved ones personally,” Androski told BioSpace. “But one area where I can make an impact today is to expose more talented future leaders to the industry and get them in the front door at the beginning of their careers.”

Leaders from healthcare company Roivant Sciences started Roivant Social Ventures in 2020 as a public charity aiming to improve healthcare access and delivery. This May, the two organizations launched a Diversity in Pharma internship program for PharmD students at UNC Eshelman School of Pharmacy to provide real-world drug development experience to individuals from diverse backgrounds..."

Click here to read the full article.


Previous
Previous

Roivant Social Ventures Launches Inaugural Convergence Forum Fellowship Program 

Next
Next

Increasing Global Access to Medicines